AHSG and metabolic syndrome: A recently published meta-analysis of 14 eligible studies showed that circulating fetuin-A levels are significantly higher in patients with MetS compared to controls, with a possible trend towards an increase in the risk of MetS with an increase in the circulating fetuin-A concentrations [87].